Allogeneic Stem Cell Transplant for Acute Myeloid Leukemia

Video

The hematologist from UC Health discussed the role of allogeneic stem cell transplant at first remission based on risk stratification.

This content originally appeared on our sister site, OncLive.

Recent Videos
Michael Flanagan, PhD, chief scientific officer at Avidity
David Barrett, JD, the chief executive officer of ASGCT
David-Alexandre C. Gros, MD, Eledon’s chief executive officer
David Barrett, JD, the chief executive officer of ASGCT
Alfred L. Garfall, MD, MS, associate professor of medicine (hematology-oncology) and director, Autologous Hematopoietic Cell Transplantation, Cell Therapy and Transplant Program, Hospital of the University of Pennsylvania; and section chief, Multiple Myeloma, Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania,
Reena Sharma, MD, an adult metabolic consultant at Salford Royal Hospital
Nirav Shah, MD, MSHP, associate professor of medicine, at the Medical College of Wisconsin
Bhagirathbhai R. Dholaria, MD, an associate professor of medicine in malignant hematology & stem cell transplantation at Vanderbilt University Medical Center
Reena Sharma, MD, an adult metabolic consultant at Salford Royal Hospital
Mark Hamilton, MD, PhD, a hematology-oncology and bone marrow transplant (BMT) cell therapy fellow at Stanford University
Related Content
CGTLive®’s Weekly Rewind

CGTLive®’s Weekly Rewind – March 21, 2025

CGTLive Staff
March 21st 2025
Article

Review top news and interview highlights from the week ending March 21, 2025.

ImmunoLogic

ImmunoLogic, Episode 2: "Charting New Frontiers in CAR T-Cell Safety" With Bruce Levine, PhD

Joseph A. Fraietta, PhD;Janna Minehart, MD;Noah Stansfield;Matt Hoffman
March 11th 2025
Podcast

In Episode 2 of ImmunoLogic, Bruce Levine, PhD, discussed the current the risk-benefit-ratio for CAR-T therapy.

Around the Helix: Cell and Gene Therapy Company Updates – March 19, 2025

Around the Helix: Cell and Gene Therapy Company Updates – March 19, 2025

Noah Stansfield
March 19th 2025
Article

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

ImmunoLogic

ImmunoLogic, Episode 1: "Chemo-Free Lymphoma? Seriously?" With Stephen J. Schuster, MD

Joseph A. Fraietta, PhD;Janna Minehart, MD;Noah Stansfield;Matt Hoffman
January 31st 2025
Podcast

In Episode 1 of ImmunoLogic, Stephen J. Schuster, MD, discussed the potential of treating lymphoma without chemotherapy.

CGTLive®’s Weekly Rewind

CGTLive®’s Weekly Rewind – March 14, 2025

CGTLive Staff
March 14th 2025
Article

Review top news and interview highlights from the week ending March 14, 2025.

Around the Helix: Cell and Gene Therapy Company Updates – March 12, 2025

Around the Helix: Cell and Gene Therapy Company Updates – March 12, 2025

Noah Stansfield
March 12th 2025
Article

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

© 2025 MJH Life Sciences

All rights reserved.